Ferrauto, GiuseppeDi Gregorio, EnzaLanzardo, StefaniaCiolli, LauraIezzi, ManuelaAime, Silvio2019-09-242019-09-242018-07-12Ferrauto, G, Di Gregorio, E, Lanzardo, S, Ciolli, L, Iezzi, M & Aime, S 2018, 'Generation of multiparametric MRI maps by using Gd-labelled-RBCs reveals phenotypes and stages of murine prostate cancer', Scientific Reports, vol. 8, 10567. https://doi.org/10.1038/s41598-018-28926-52045-2322http://hdl.handle.net/2164/12984We acknowledge BRACCO Imaging for providing Gadoteridol (ProHance). This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 668119 (project “IDentIFY”) and No 667510 (project “GLINT”) and it was performed in the framework of COST Action AC15209 (EURELAX). E.D.G. and G.F. were supported by FIRC-AIRC (Fondazione Italiana per la Ricerca sul Cancro AIRC) fellowships.6381410engSDG 3 - Good Health and Well-beingcancerdiagnostic markerstumour biomarkerstumour heterogeneityurological cancerR MedicineQC PhysicsGeneralEuropean Commission668119667510RQCGeneration of multiparametric MRI maps by using Gd-labelled-RBCs reveals phenotypes and stages of murine prostate cancerJournal article10.1038/s41598-018-28926-5http://www.scopus.com/inward/record.url?scp=85049902910&partnerID=8YFLogxK8